Cardiovate develops innovative medical devices and products that utilize proprietary materials and processes to address clinical needs in tissue regeneration and repair. Their technology, including the Cardiovate scaffold, promotes the growth of viable tissue for the repair or replacement of damaged and diseased vasculature. By targeting transformational healthcare opportunities, Cardiovate aims to reduce failure rates and decrease the total cost of care through the development of next-generation vascular regeneration technology.